A radioreceptor assay for neuroleptic drugs
The routine monitoring of blood levels of drugs such as digoxin, gentamicin, lithium and anticonvulsants has been recognized as a valuable and necessary aid to clinical management. A similar approach to the control of therapy with antipsychotic, neuroleptic drugs has been complicated by (1) the large number of drugs presently in use, (2) their even larger number of active and inactive metabolites, (3) the lack of satisfactory assay procedures, and (4) a general lack of recognition of the toxic effects which may result from high dose levels.
KeywordsDopamine Propranolol Prolactin Digoxin Nortriptyline
Unable to display preview. Download preview PDF.
- Brunswick, D. J. and Mendels, J. (1977). Reduced levels of tricyclic antidepressants in plasma from vacutainers. Commun. Psychopharmac., 1, 131Google Scholar
- Creese, I. and Sibley, D. (1979). Radioligand binding studies: evidence for multiple dopamine receptors. Commun. Psychopharmac., 3, 385–95Google Scholar
- Jeste, D. V., Rosenblatt, J. E., Wagner, R. L. and Wyatt, R. J. (1979). High serum neuroleptic levels in tardive dyskinesia? New Engl. J. Med., 1184Google Scholar
- Koch, M. H. J. (1974). The conformation of neuroleptic drugs. Molec. Pharmac., 10, 425–37Google Scholar
- McDevitt, D. G., Frisk-Holmberg, M., Hollifield, J. W. and Shand, D. G. (1976). Plasma binding and the affinity of propanolol for a beta receptor in man. Clin. Pharmac. Ther., 20, 152–7Google Scholar
- Patzke, J., Lai, A., Glueck, B. L., Shaskan, E. G. and Rosenby, B. J. (1980). A radioreceptor assay for the measurement of neuroleptic drugs. Clin. Chem., 26, 799Google Scholar
- Rosenblatt, J. E., Pary, R. J., Bigelow, L. B., DeLisi, L. E., Wagner, R. L., Kleinman, J. E., Weinberger, D. R., Potkin, S. G., Schiling, D., Jeste, D. V., Alexander, P. and Wyatt, R. J. (1980). Measurement of serum neuroleptic concentrations by radioreceptor assay: concurrent assessment of clinical response and toxicity. Psychopharmac.Bull., in press.Google Scholar
- Sakalis, G., Chan, T. L., Sathananthan, G., Schooler, N., Goldberg, S. and Gershon, S. (1977). Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios. Commun. Psychopharmac., 1, 157–66Google Scholar
- Snyder, S. H., Creese, I. and Burt, D. R. (1975). The brain’s dopamine receptor: labeling with [3H]dopamine and [3H]haloperidol. Psychopharmac Commun., 1, 663–73Google Scholar